Aardvark Therapeutics Faces Class Action Over Misleading Safety Claims of ARD-101 #USA #New_York #Aardvark_Therapeutics #AARD #Bryan_Jones

Aardvark Therapeutics Faces Class Action Over Misleading Safety Claims of ARD-101 #USA #New_York #Aardvark_Therapeutics #AARD #Bryan_Jones
Investigation into Aardvark Therapeutics Securities Class Action Amid Safety Claims #USA #New_York #Bryan_Jones #AARD_stock #Aardvark_Inc